Non-Current Assets
Equity Securities (FV-NI and No Readily Determinable FV) - Cost
UnitedHealth Group Equity Securities (FV-NI and No Readily Determinable FV) - Cost remained flat by 0.0% to $5.50B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $5.10B to $5.50B. Over 5 years (FY 2020 to FY 2025), Equity Securities (FV-NI and No Readily Determinable FV) - Cost shows an upward trend with a 19.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2018
Last reportedQ1 2026May 5, 2026
How to read this metric
Changes in this balance reflect new investments or divestitures of equity stakes.
Detailed definition
The historical cost basis of equity investments that are measured at fair value through net income or those that do not...
Peer comparison
Common in companies with active venture capital or strategic investment arms.
Metric ID:
equity_securities_fvni_no_fv_costHistorical Data
18 periods
| Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.90B | $3.50B | $3.40B | $3.40B | $3.70B | $3.90B | $4.20B | $4.20B | $4.90B | $4.10B | $4.20B | $4.90B | $4.90B | $5.10B | $5.40B | $5.60B | $5.50B | $5.50B |
| QoQ Change | — | +20.7% | -2.9% | +0.0% | +8.8% | +5.4% | +7.7% | +0.0% | +16.7% | -16.3% | +2.4% | +16.7% | +0.0% | +4.1% | +5.9% | +3.7% | -1.8% | +0.0% |
| YoY Change | — | — | — | +17.2% | +5.7% | — | +23.5% | +23.5% | +32.4% | +5.1% | +0.0% | +16.7% | +0.0% | +24.4% | +28.6% | +14.3% | +12.2% | +7.8% |
Range$2.90B – $5.60B
CAGR+16.3%
Avg YoY Growth+15.1%
Median YoY Growth+15.5%
Equity Securities (FV-NI and No Readily Determinable FV) - Cost at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's equity securities (fv-ni and no readily determinable fv) - cost?
- UnitedHealth Group (UNH) reported equity securities (fv-ni and no readily determinable fv) - cost of $5.50B in Q1 2026.
- How has UnitedHealth Group's equity securities (fv-ni and no readily determinable fv) - cost changed year-over-year?
- UnitedHealth Group's equity securities (fv-ni and no readily determinable fv) - cost increased by 7.8% year-over-year, from $5.10B to $5.50B.
- What is the long-term trend for UnitedHealth Group's equity securities (fv-ni and no readily determinable fv) - cost?
- Over 5 years (2020 to 2025), UnitedHealth Group's equity securities (fv-ni and no readily determinable fv) - cost has grown at a 19.0% compound annual growth rate (CAGR), from $2.30B to $5.50B.
- What does equity securities (fv-ni and no readily determinable fv) - cost mean?
- The original cost of equity investments held by the company.